JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphomaJaroslav Žák, John R. Teijaro, Isaraphorn Pratumchai et al.|Science|2024Cited by 173
An RNAi Screen Identifies TRRAP as a Regulator of Brain Tumor-Initiating Cell DifferentiationHeiko Wurdak, Peter G. Schultz, Hannes Vogel et al.|Cell stem cell|2010Cited by 134
Discovery of Small Molecules for the Reversal of T Cell ExhaustionBrett S. Marro, Michael B. A. Oldstone, Jaroslav Žák et al.|Cell Reports|2019Cited by 49
Synthesis and biological evaluation of novel FiVe1 derivatives as potent and selective agents for the treatment of mesenchymal cancersFrancisco Martínez‐Peña, Luke L. Lairson|European Journal of Medicinal Chemistry|2022Cited by 9
Myeloid reprogramming by JAK inhibition enhances checkpoint blockade therapyJaroslav Žák, John R. Teijaro, Isaraphorn Pratumchai et al.|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 6